Search
for
Sort by
Research 121–150 of 1000+
- Advances in the management of alopecia areata
- 5% Minoxidil topical foam for men: Hair growth in millennials – a post hoc analysis
- Alopecia in patients treated with molecularly targeted anticancer therapies
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
- The Safety and Efficacy of a Novel Saw Palmetto ( <i>Serenoa repens</i> ) Extract for Promoting Hair Growth in Adults With Self‐Perceived Thinning Hair: 180‐Day Results
- Topical ketoconazole: a systematic review of current dermatological applications and future developments
- Androgens and acne: perspectives on clascoterone, the first topical androgen receptor antagonist
- Male hormonal contraception: looking back and moving forward
- REPORTS: Summary of the Recommendations on Sexual Dysfunctions in Women
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Teriflunomide: a novel oral treatment for relapsing multiple sclerosis
- Non-hemorrhage-related adverse effects of rivaroxaban
- The role of dutasteride in the treatment of benign prostatic obstruction and related conditions
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Alopecia Areata: Current Treatments and New Directions
- Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician’s Choice Standard-of-Care Chemotherapy
- Growth Factor Cocktail Including Fibroblast Growth Factor 9 (Cellcurin) in the Treatment of Androgenetic Alopecia in Men and Women: A Randomized Controlled Trial
- Calcipotriene plus betamethasone dipropionate gel: a new combination therapy for scalp psoriasis
- Combination of Intense Pulsed Light and Topical Eflornithine Therapy Versus Intense Pulsed Light Alone in the Treatment of Idiopathic Facial Hirsutism: A Randomized Controlled Trial
- Efficacy and Safety of Mesotherapy With 0.5% Minoxidil Versus Topical 2% Minoxidil for Female Androgenetic Alopecia: A Randomized Controlled Trial
- Comparative study between mesotherapy and topical 5% minoxidil by dermoscopic evaluation for androgenic alopecia in male: A randomized controlled trial
- Effect of a medicinal and edible decoction YH0618 on chemotherapy-induced dermatologic toxicity: a randomized controlled trial
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- Empirical evidence of observer bias in randomized clinical trials: updated and expanded analysis of trials with both blinded and non-blinded outcome assessors
- The placebo effect and randomized trials: analysis of conventional medicine
- Randomized Clinical Trial to Evaluate the Effect of Probiotic Intake on Androgenic Alopecia
- A Randomized Double-Blind, Placebo-Controlled Study to Evaluate the Anti-Skin-Aging Effect of LactoSporin – The Extracellular Metabolite from Bacillus coagulans (Weizmannia coagulans) MTCC 5856 in Healthy Female Volunteers
- Is the Addition of Oral Biotin to PRP More Beneficial for Treating Male Pattern Hair Loss Compared to PRP Alone? A Randomized Control Trial
- Randomized controlled trial on the efficacy and safety of the combination therapy of topical 0.1% finasteride − 5% Minoxidil in male androgenetic alopecia
- Faculty Opinions recommendation of Low-level light therapy for androgenetic alopecia: a 24-week, randomized, double-blind, sham device-controlled multicenter trial.